Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ADAP |
---|---|---|
09:32 ET | 8602 | 1.185 |
09:34 ET | 21136 | 1.2 |
09:36 ET | 3139 | 1.2005 |
09:38 ET | 6500 | 1.21 |
09:39 ET | 42998 | 1.19 |
09:41 ET | 32244 | 1.21 |
09:43 ET | 5000 | 1.1901 |
09:45 ET | 9901 | 1.2 |
09:48 ET | 6300 | 1.2 |
09:50 ET | 800 | 1.1917 |
09:52 ET | 300 | 1.2 |
09:54 ET | 9897 | 1.19 |
09:56 ET | 130 | 1.185 |
09:57 ET | 200 | 1.2 |
09:59 ET | 12710 | 1.15 |
10:01 ET | 300 | 1.18 |
10:03 ET | 100 | 1.15 |
10:06 ET | 25060 | 1.19 |
10:08 ET | 1000 | 1.19 |
10:10 ET | 6280 | 1.185 |
10:12 ET | 300 | 1.1884 |
10:14 ET | 300 | 1.19 |
10:15 ET | 1600 | 1.19 |
10:17 ET | 10000 | 1.19 |
10:21 ET | 8015 | 1.17 |
10:24 ET | 4100 | 1.16 |
10:33 ET | 100 | 1.16 |
10:39 ET | 108 | 1.1618 |
10:46 ET | 2775 | 1.17 |
10:48 ET | 200 | 1.18 |
10:50 ET | 500 | 1.1729 |
10:51 ET | 300 | 1.18 |
10:53 ET | 100 | 1.17 |
10:55 ET | 300 | 1.18 |
10:57 ET | 300 | 1.18 |
11:00 ET | 202 | 1.16 |
11:02 ET | 300 | 1.18 |
11:04 ET | 100 | 1.18 |
11:06 ET | 100 | 1.1705 |
11:08 ET | 2200 | 1.1696 |
11:09 ET | 100 | 1.18 |
11:13 ET | 300 | 1.18 |
11:15 ET | 500 | 1.175 |
11:18 ET | 300 | 1.18 |
11:22 ET | 200 | 1.18 |
11:26 ET | 445 | 1.18 |
11:27 ET | 100 | 1.18 |
11:31 ET | 100 | 1.18 |
11:33 ET | 500 | 1.19 |
11:36 ET | 2900 | 1.1701 |
11:38 ET | 2600 | 1.1701 |
11:40 ET | 200 | 1.19 |
11:42 ET | 103 | 1.1752 |
11:44 ET | 7600 | 1.1701 |
11:45 ET | 3300 | 1.1701 |
11:47 ET | 300 | 1.18 |
11:49 ET | 500 | 1.175 |
11:51 ET | 1041 | 1.18 |
11:54 ET | 15300 | 1.19 |
11:56 ET | 200 | 1.19 |
11:58 ET | 100 | 1.19 |
12:00 ET | 20503 | 1.16 |
12:02 ET | 559 | 1.18 |
12:03 ET | 200 | 1.18 |
12:05 ET | 100 | 1.18 |
12:07 ET | 2200 | 1.176 |
12:09 ET | 100 | 1.18 |
12:14 ET | 198 | 1.1607 |
12:18 ET | 1000 | 1.17 |
12:23 ET | 200 | 1.18 |
12:30 ET | 2134 | 1.1681 |
12:32 ET | 137 | 1.16 |
12:36 ET | 1000 | 1.165 |
12:41 ET | 150 | 1.1624 |
12:50 ET | 1142 | 1.16 |
12:52 ET | 1421 | 1.16 |
12:57 ET | 12400 | 1.14 |
12:59 ET | 1000 | 1.1497 |
01:03 ET | 100 | 1.15 |
01:06 ET | 200 | 1.149 |
01:08 ET | 300 | 1.1499 |
01:15 ET | 260 | 1.14 |
01:17 ET | 3139 | 1.14 |
01:19 ET | 100 | 1.14 |
01:28 ET | 200 | 1.14 |
01:30 ET | 300 | 1.14 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Adaptimmune Therapeutics PLC | 299.0M | -2.2x | --- |
MacroGenics Inc | 274.0M | -12.1x | --- |
Poseida Therapeutics Inc | 272.4M | -2.1x | --- |
Innate Pharma SA | 200.3M | -25.5x | --- |
Codexis Inc | 254.7M | -3.9x | --- |
Enanta Pharmaceuticals Inc | 273.1M | -2.1x | --- |
Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. The Company is focused on providing cell therapies to people with cancer. Its engineered T-cell receptor (TCR) platform enables the engineering of T-cells to target and destroy cancers across multiple solid tumor types. Its cell therapy candidates include TCR T-cells and TruC T-cells. Its product candidates include afamitresgene autoleucel (afami-cel) and Lete-cel. The afamicel is a cell therapy that provides a treatment option for people with synovial sarcoma. The Company is in the process of transitioning lete-cel, which targets the NY-ESO antigen in people with synovial sarcoma and myxoid round cell liposarcoma (MRCLS). Its clinical pipeline includes SURPASS-III Phase II Trial with ADP-A2M4CD8 and SURPASS Phase I Trial with ADP-A2M4CD8. The Company’s most advanced pre-clinical programs are for T-cell therapies directed to the PRAME target (ADP-600) and to CD70 (ADP-520). ADAP-600 is an engineered TCR T-cell.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $299.0M |
---|---|
Revenue (TTM) | $60.3M |
Shares Outstanding | 255.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.35 |
EPS | $-0.52 |
Book Value | $0.17 |
P/E Ratio | -2.2x |
Price/Sales (TTM) | 5.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -195.24% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.